Free shipping on all orders over $ 500

Ursodeoxycholic acid sodium

Cat. No. M13985

All AbMole products are for research use only, cannot be used for human consumption.

Ursodeoxycholic acid sodium Structure
Synonym:

Ursodeoxycholate sodium; Ursodiol sodium; UCDA sodium

Size Price Availability Quantity
50mg USD 25 In stock
100mg USD 35 In stock
500mg USD 98 In stock
1g USD 175 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Ursodeoxycholic acid (Ursodeoxycholate) sodium is a secondary bile acid issued from the transformation of (cheno)deoxycholic acid by intestinal bacteria, acting as a key regulator of the intestinal barrier integrity and essential for lipid metabolism. Ursodeoxycholic acid sodium acts as signaling molecule, exerting its effects by interacting with bile acid activated receptors, including G-protein coupled bile acid receptor 5 (TGR5, GPCR19) and the farnesoid X receptor (FXR). Ursodeoxycholic acid sodium can be used for the research of a variety of hepatic and gastrointestinal diseases. Orally active.

Chemical Information
Molecular Weight 414.55
CAS Number 2898-95-5
Solubility (25°C) DMSO 90 mg/mL
Storage 2-8°C, dry, sealed
References

[1] Xintong Zhang, et al. The influence of the gut microbiota on the bioavailability of oral drugs

[2] Aliya F Gulamhusein, et al. Primary biliary cholangitis: pathogenesis and therapeutic opportunities

[3] Huey-Ling Chen, et al. Jaundice revisited: recent advances in the diagnosis and treatment of inherited cholestatic liver diseases

[4] Lili Ding, et al. Bile acid nuclear receptor FXR and digestive system diseases

[5] Nisanne S Ghonem, et al. Fibrates and cholestasis

Related GPCR19/TGR5 Products
TGR5 Receptor Agonist

TGR5 Receptor Agonist is a potent TGR5(GPCR19) agonist which showed improved potency in the U2-OS cell assay (pEC50 = 6.8) and in melanophore cells (pEC50 = 7.5).

Deoxycholic acid sodium salt

Deoxycholic acid sodium salt is a bile acid and a by-product of intestinal metabolism, Deoxycholic acid sodium salt can activate the G protein-coupled bile acid receptor TGR5.

BAR 502

BAR502 is a dual agonist of FXR and GPBAR1 with IC50 values of 2 μM and 0.4 μM, respectively.

INT-777

INT-777 is a potent TGR5 agonist with EC50 of 0.82 μM. In animal models, INT-777 alleviates liver injury by activating TGR5, thereby increasing bile flow and reducing bile acid synthesis. TGR5 signalling mediated by INT-777 induces the release of GLP-1 (glucagon-like peptide-1), improving liver and pancreatic function in obese mice.

SBI-115

SBI-115 is a TGR5 (GPCR19) antagonist, it decreases hepatic cystogenesis with polycystic liver diseases via inhibiting TGR5.

  Catalog
Abmole Inhibitor Catalog




Keywords: Ursodeoxycholic acid sodium, Ursodeoxycholate sodium; Ursodiol sodium; UCDA sodium supplier, GPCR19/TGR5, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.